These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 16962230

  • 1. Placenta increta: Use of dynamic MRI for diagnosis and evaluation of placental vascularity.
    Honnma H, Endo T, Hayashi T, Saito T.
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):131-3. PubMed ID: 16962230
    [No Abstract] [Full Text] [Related]

  • 2. Magnetic resonance imagining (MRI) and serial beta-human chorionic gonadotrophin (beta-hCG) follow up for placenta percreta.
    El-Bialy G, Kassab A, Armstrong M.
    Arch Gynecol Obstet; 2007 Oct; 276(4):371-3. PubMed ID: 17356825
    [Abstract] [Full Text] [Related]

  • 3. Placenta increta: evaluation of radiological investigations and therapeutic options of conservative management.
    Panoskaltsis TA, Ascarelli A, de Souza N, Sims CD, Edmonds KD.
    BJOG; 2000 Jun; 107(6):802-6. PubMed ID: 10847240
    [No Abstract] [Full Text] [Related]

  • 4. Placenta percreta: methotrexate treatment and MRI findings.
    Heiskanen N, Kröger J, Kainulainen S, Heinonen S.
    Am J Perinatol; 2008 Feb; 25(2):91-2. PubMed ID: 18176907
    [Abstract] [Full Text] [Related]

  • 5. Conservative treatment of placenta increta with methotrexate.
    Crespo R, Lapresta M, Madani B.
    Int J Gynaecol Obstet; 2005 Nov; 91(2):162-3. PubMed ID: 16126207
    [No Abstract] [Full Text] [Related]

  • 6. Committee opinion no. 529: placenta accreta.
    Committee on Obstetric Practice.
    Obstet Gynecol; 2012 Jul; 120(1):207-11. PubMed ID: 22914422
    [Abstract] [Full Text] [Related]

  • 7. Successful uterus-preserving surgery for treatment of chemotherapy-resistant placenta increta.
    Endo T, Hayashi T, Shimizu A, Matsuura M, Mizuuchi M, Nagasawa K, Ezaka Y, Baba T, Ishioka S, Saito T.
    Gynecol Obstet Invest; 2010 Jul; 69(2):112-5. PubMed ID: 19955809
    [Abstract] [Full Text] [Related]

  • 8. Partial placenta increta and methotrexate therapy: three case reports.
    Pinho S, Sarzedas S, Pedroso S, Santos A, Rebordão M, Avillez T, Casal E, Hermida M.
    Clin Exp Obstet Gynecol; 2008 Jul; 35(3):221-4. PubMed ID: 18754299
    [Abstract] [Full Text] [Related]

  • 9. Conservative management of placenta increta: case report and literature review.
    Yarandi F, Eftekhar Z, Shojaei H, Rahimi-Sharbaf F, Baradaran F.
    Acta Med Iran; 2011 Jul; 49(6):396-8. PubMed ID: 21874645
    [Abstract] [Full Text] [Related]

  • 10. Using methotrexate to treat placenta accreta.
    Cole MD.
    AWHONN Lifelines; 2002 Dec; 6(6):486-7. PubMed ID: 12593248
    [No Abstract] [Full Text] [Related]

  • 11. [Case report: seventeen year old primipara with placenta increta, treated with methotrexate].
    Arnadottir BT, Hardardóttir H, Marvinsdóttir B.
    Laeknabladid; 2008 Jul; 94(7-8):549-52. PubMed ID: 18591730
    [Abstract] [Full Text] [Related]

  • 12. Human placental lactogen and color Doppler in predicting expulsion of retained adherent placenta: a new clinical observation.
    Zepiridis L, Zafrakas M, Theodoridis TD, Assimakopoulos E, Tzevelekis P, Athanatos D, Bontis JN, Tarlatzis BC.
    Arch Gynecol Obstet; 2009 Dec; 280(6):1041-4. PubMed ID: 19333613
    [Abstract] [Full Text] [Related]

  • 13. A myotonic dystrophy 1 patient complicated with placental adherence after miscarriage of one dichorionic diamniotic twin following her tenth in vitro fertilization and embryo transfer.
    Endo T, Baba T, Sugio A, Morishita M, Takahashi M, Akashi Y, Ishioka S, Tachi N, Imai T, Tamakawa M, Saito T.
    Arch Gynecol Obstet; 2012 Dec; 286(6):1605-8. PubMed ID: 23011730
    [No Abstract] [Full Text] [Related]

  • 14. The morbidly adherent placenta: diagnosis and management options.
    Hayes E, Ayida G, Crocker A.
    Curr Opin Obstet Gynecol; 2011 Dec; 23(6):448-53. PubMed ID: 22002113
    [Abstract] [Full Text] [Related]

  • 15. Ovarian pregnancy successfully treated with methotrexate.
    Habbu J, Read MD.
    J Obstet Gynaecol; 2006 Aug; 26(6):587-8. PubMed ID: 17000523
    [No Abstract] [Full Text] [Related]

  • 16. Placenta increta after first-trimester dilatation and curettage manifesting as an unusual uterine mass: magnetic resonance findings.
    Ju W, Kim SC.
    Acta Radiol; 2007 Oct; 48(8):938-40. PubMed ID: 17924226
    [Abstract] [Full Text] [Related]

  • 17. Log-linear human chorionic gonadotropin elimination in cases of retained placenta percreta.
    Stitely ML, Gerard Jackson M, Holls WH.
    Arch Gynecol Obstet; 2014 Feb; 289(2):259-62. PubMed ID: 23843154
    [Abstract] [Full Text] [Related]

  • 18. Preservation of fertility and subsequent childbirth after methotrexate treatment of placenta percreta: a case report.
    Tamate M, Matsuura M, Habata S, Akashi Y, Tanaka R, Ishioka S, Endo T, Saito T.
    J Med Case Rep; 2015 Oct 19; 9():232. PubMed ID: 26480940
    [Abstract] [Full Text] [Related]

  • 19. Placental blood flow disappears coincident with a fall in human chorionic gonadotropin to undetectable levels in conservative management of placenta accreta.
    Imai S, Kondoh E, Kawasaki K, Mogami H, Ueda A, Umeoka S, Konishi I.
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep 19; 180():199-201. PubMed ID: 24916034
    [No Abstract] [Full Text] [Related]

  • 20. [Interstitial Pregnancy. Ultrasonographic diagnosis and contribution of MRI. A case report].
    Bourdel N, Roman H, Gallot D, Lenglet Y, Dieu V, Juillard D, Linstrument C, Botchorishvili R, Rabishong B, Mage G, Canis M.
    Gynecol Obstet Fertil; 2007 Feb 19; 35(2):121-4. PubMed ID: 17223605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.